Topics

A pick-the-winner #clinicaltrial design in patients with metastatic triple-negative #breastcancer shows that immune induction with #doxorubicin or #cisplatin may improve clinical responses to #PD-1 blockade #NMEDClinical #immunotherapy @NKI_nl | http://go

09:00 EST 4 Dec 2019 | Nature Publishing

A pick-the-winner design in patients with metastatic triple-negative shows that immune induction with or may improve clinical responses to -1 blockade | http://go.nature.com/2Q5gjLv 

Original Article: A pick-the-winner #clinicaltrial design in patients with metastatic triple-negative #breastcancer shows that immune induction with #doxorubicin or #cisplatin may improve clinical responses to #PD-1 blockade #NMEDClinical #immunotherapy @NKI_nl | http://go

NEXT ARTICLE

More From BioPortfolio on "A pick-the-winner #clinicaltrial design in patients with metastatic triple-negative #breastcancer shows that immune induction with #doxorubicin or #cisplatin may improve clinical responses to #PD-1 blockade #NMEDClinical #immunotherapy @NKI_nl | http://go"

Quick Search